Navigation Links
Raptor Pharmaceuticals Corp. Announces Presentation at 5th International Cystinosis Conference 2008
Date:6/23/2008

tor currently has eight patent applications under review in the U.S. and abroad, as well as four provisional patent applications in the U.S. In addition, Raptor has licensed two provisional patent applications from Washington University and one patent application and one provisional patent application from UC San Diego.

For additional information, please visit http://www.raptorpharma.com.

FORWARD LOOKING STATEMENTS

This document contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements relate to future events or our future results of operation or future financial performance, including, but not limited to the following statements: Raptor's ability to develop DR Cysteamine for the treatment of Cystinosis; Raptor's ability to formulate and manufacture DR Cysteamine in clinical quantities to support clinical trials; DR Cysteamine's ability to reduce side effects, reduce dosage and/or frequency of dosing in Cystinosis patients; and DR Cysteamine's ability to improve the quality of life of families affected by Cystinosis. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, which may cause our actual results to be materially different from these forward-looking statements. Factors which may significantly change or prevent our forward looking statements from fruition include that we may be unsuccessful in developing any products or acquiring products; that our technology may not be validated as we progress further and our methods may not be accepted by the scientific community; that we are unable to retain or attract key employees whose knowledge is essential to the development of our products; that unforeseen scientific difficulties develop with our process; that our patents are not sufficient to protect essential aspects of our technology; that competitors may inven
'/>"/>

SOURCE Raptor Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Raptor Pharmaceuticals Corp. To Present at BIO 2008 International Convention
2. Raptor Pharmaceuticals Corp. Receives FDA Orphan Drug Designation for Cysteamine in Huntingtons Disease
3. Raptor Pharmaceuticals Corp. Enters Agreements to Advance Clinical Pipeline
4. Raptor Pharmaceuticals Acquires Orphan Clinical Program
5. Onyx Pharmaceuticals to Present at Jefferies 2nd Annual Healthcare Conference
6. Sunesis Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference
7. Immtech Pharmaceuticals and Beijing Capital Medical University Announce Joint Venture to Provide Contract Research Services in China
8. Synovics Pharmaceuticals Announces Continued Growth of Customer Relationships
9. GANIC Pharmaceuticals Launched with Premier Pharmaceutical Industry Executives
10. Barrett Katz, MD, MBA, Named CEO of Danube Pharmaceuticals
11. William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 This webinar ... on nonclinical and clinical safety assessment in biosimilars. ... guide a path for biosimilar drug development, however ... of biosimilarity with regards to quality, safety and ... of biosimilar drug development and registration, development strategies ...
(Date:1/15/2014)... NC (PRWEB) January 15, 2014 ... an enhancement to its Online Web Portal for Life ... now have the ability to specify the subject matter ... nearly 50 life science sub-domains. This will help reduce ... and scientific fields, and decrease the likelihood of error. ...
(Date:1/14/2014)... Doylestown, PA (PRWEB) January 14, 2014 ... – 11 p.m. , Location: Warrington Country Club, 1360 ... Hepatitis B Foundation, the only national nonprofit organization solely ... improving the quality of life for those affected worldwide, ... 11 at Warrington Country Club in Warrington, Pa. ...
(Date:1/14/2014)... York, NY (PRWEB) January 14, 2014 ... initiated coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua ... and marketing proprietary products to serve the wound ... , In late 2012, Alliqua was restructured ... launched the company’s new strategy to become a ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company") ... today announces that application has been sought for 530,000 new ... admitted to trading on AIM. The new Ordinary Shares are ... Philip Haworth, former Chief Executive Officer of Silence. ...
... WEST LAFAYETTE, Ind. ╨ Engineers have discovered details about ... new applications in manufacturing, diagnostics and other research., ... create features and surface textures in metals, ceramics and other ... biosensors. The lasers pulse at durations of 100 femtoseconds, or ...
... CAMBRIDGE, Mass., Dec. 19, 2011 Access Industries ... a new life sciences venture investment initiative to ... team,s experience in startup creation, technology commercialization and ... and also create de-novo spinoffs around potential high-impact ...
Cached Biology Technology:Silence Therapeutics Additional Listing 2Silence Therapeutics Additional Listing 3Research could improve laser-manufacturing technique 2Access BridgeGap Ventures to Focus on Early-Stage Therapeutic Opportunities 2Access BridgeGap Ventures to Focus on Early-Stage Therapeutic Opportunities 3
(Date:4/15/2014)... of Arts and Sciences (KNAW) has announced the names ... prestigious Heineken Prizes (one million US dollars prize money ... their great merits to science. , This year marks ... to the Austrian-American chemist Erwin Chargaff in 1964. , ... to the following laureates: , Christopher M. ...
(Date:4/15/2014)... soon could be powering the forklifts used in warehouses ... faster refueling times than ever before, courtesy of a ... (HHC). , The goal of the project is to ... at low pressure four to five times faster than ... a competitive advantage over batteries for a big slice ...
(Date:4/14/2014)... to unravel the molecular changes that underlie one of ... When the bacterium Yersinia pestis enters the lungs, it ... fatal if untreated. The way in which Y. ... in a matter of days has largely confounded scientists, ... the presence of a protein called the plasminogen activator ...
Breaking Biology News(10 mins):Five scientists awarded prestigious Heineken Prizes 2Low-cost, hydrogen-powered forklifts with rapid refueling, zero emissions coming soon 2Low-cost, hydrogen-powered forklifts with rapid refueling, zero emissions coming soon 3Low-cost, hydrogen-powered forklifts with rapid refueling, zero emissions coming soon 4Plague alters cell death to kill host 2
... Iceland,s Eyjafjallajoekull volcano have produced a 1600 km-wide ash ... and then south, is clearly visible in stark contrast ... May. The volcano began emitting steam and ash ... month. Renewed activity earlier this week caused some flights ...
... Assistant Professor Carla Finkielstein has been presented with a ... by the American Association for Cancer Research (AACR), is ... researchers and increase the recognition of minorities involved in ... in the Department of Biological Sciences in the College ...
... a leading scientist at the Office of Naval Research, discussed ... and wastewater during National Public Radio,s recent "Science Friday" segment. ... of the microbial fuel cell to power different types of ... program officer for ONR,s Naval Biosciences and Biocentric Technology Program. ...
Cached Biology News:Biologist Carla Finkielstein receives Minority Scholar Award 2ONR scientist generates 'mud power' for NPR radio audience 2
... is the universal bioinformatics software that has ... The unique modular design of BioNumerics allows ... any type of data employed for the ... DNA fingerprints, 2-D protein gels, HPLC, VNTR, ...
Request Info...
Cultrex 3D Culture Matrix Rat Collagen I....
Cultrex 3D Culture Matrix BME....
Biology Products: